Cited by 78Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis Research

Retrotransposon activation contributes to fragile X premutation rCGG-mediated neurodegeneration

Open access
Tan, H., Qurashi, A., Poidevin, M., Nelson, D. L., Li, H., Jin, P.·2012·Human Molecular Genetics

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder associated with fragile X premutation carriers. Previous studies have shown that fragile X rCGG repeats are sufficient to cause neurodegeneration and that the rCGG-repeat-binding proteins Pur α and heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 could modulate rCGG-mediated neuronal toxicity. Mobile genetic elements or their remnants populate the genomes, and the activities of these elements are tightly controlled for the fitness of host genomes in different organisms. Here we provide both biochemical and genetic evidence to show that the activation of a specific retrotransposon, gypsy, can modulate rCGG-mediated neurodegeneration in an FXTAS Drosophila model. We find that one of the rCGG-repeat-binding proteins, hnRNP A2/B1, is involved in this process via interaction with heterochromatin protein 1. Knockdown of gypsy RNA by RNAi could suppress the neuronal toxicity caused by rCGG repeats. These data together point to a surprisingly active role for retrotransposition in neurodegeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddr437

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • L1 activity has been implicated in a variety of age-related disorders, including cancer and neurodegeneration.

    “L1 activity has been implicated in a variety of age-related disorders12, including cancer7,13 and neurodegeneration14,15.”

    From SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age (2014) · cites this paper as [15]

    The Discussion reports that retrotransposon activation contributes to neurodegeneration in a fragile X fly model, supporting the neurodegeneration portion at the level of retrotransposons generally. It identifies gypsy, not L1, as the retrotransposon whose reduction suppresses neuronal toxicity; its discussion of cancer likewise does not implicate L1 specifically. The paper therefore does not support the broader claim about L1 activity across age-related disorders. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. Warren, S.T. and Sherman, S.L. (2001) Scriver, C.R., Beaudet, A.L., Valle, D., Childs, B., Kinzler, K.W. and Vogelstein, B. (eds), The Metabolic & Molecular Bases of Inherited Disease. Vol. 1. McGraw-Hill Companies, New York, pp. 1257-1290.
  2. Hagerman, R.J. (ed.), Fragile X Syndrome: Diagnosis, Treatment and Research. The Johns Hopkins University Press, Baltimore, MD, pp. 136-168.
  3. Jin, P., Zarnescu, D.C., Zhang, F., Pearson, C.E., Lucchesi, J.C., Moses, K. and Warren, S.T. (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron, 39, 739-747.
  4. SanMiguel, P., Tikhonov, A., Jin, Y.K., Motchoulskaia, N., Zakharov, D., Melake-Berhan, A., Springer, P.S., Edwards, K.J., Lee, M., Avramova, Z. et al. (1996) Nested retrotransposons in the intergenic regions of the maize genome. Science, 274, 765 -768.
  5. Xing, J., Wang, H., Belancio, V.P., Cordaux, R., Deininger, P.L. and Batzer, M.A. (2006) Emergence of primate genes by retrotransposon-mediated sequence transduction. Proc. Natl Acad. Sci. USA, 103, 17608-17613.
  6. Ostertag, E.M., DeBerardinis, R.J., Goodier, J.L., Zhang, Y., Yang, N., Gerton, G.L. and Kazazian, H.H. Jr. (2002) A mouse model of human L1 retrotransposition. Nat. Genet., 32, 655-660. 64 Human Molecular Genetics, 2012, Vol. 21, No. 1

Cited by

Sorted by citations

Authors
Tan, H., Qurashi, A., Poidevin, M., Nelson, D. L., Li, H., & Jin, P.
Affiliations
  • Emory University (US)
  • Baylor College of Medicine (US)
  • Huazhong University of Science and Technology (CN)
Corresponding author
  • Li, H.
  • Jin, P.
Venue
Human Molecular Genetics
Published
2011-09-22
Volume
21
Issue
1
Pages
57-65
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2099637873
Cited by
78
References
2
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 8 · 2020: 11 · 2019: 11 · 2018: 7 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 3 · 2012: 5
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Ataxia Foundation
  • China Scholarship Council
  • National Institute of Mental Health (R01MH076090)
  • National Institute of Neurological Disorders and Stroke (R01NS051630, R21NS067461)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
fragile X premutation, fragile X-associated tremor/ataxia syndrome, retrotransposon activation, gypsy retrotransposon, neurodegeneration, HNRNPA2B1, Purα, HP1, Drosophila model, mobile genetic elements, RNA interference
MeSH terms
Animals, Disease Models, Animal, Drosophila, Eye, Female, Humans, Male, Neurons, Retroelements, Neurodegenerative Diseases, Trinucleotide Repeat Expansion, Drosophila Proteins, Heterogeneous-Nuclear Ribonucleoprotein Group A-B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review